ASCENTAGE PHARMA GROUP INTERNATIONAL · 亚盛医药
Last · HKSEHK$28.02-1.28 (-4.37%)close · yahoo · 11h ago
Market capHK$10.5B373.6M sh
P/E · TTM-6.4fwd -72.4 · eps -4.41 · loss
Beta0.66vs S&P 500
Div yield0.00%annual · TTM
52w range
HK$27.12HK$74.65
Volume2.8Msession
| Revenue | ¥642.6M |
|---|---|
| Operating income | ¥-1.4B |
| Net income | ¥-1.5B |
| Operating margin | -218.1% |
| Net margin | -227.5% |
| Return on equity | -262.8% |
| Period | TTM 2026-06-30 |
Loading chart…
Press & signals
- GlobeNewswire
Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
- GlobeNewswire
Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer
- GlobeNewswire
Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026
Documents
FormReporting forFiledFlags